Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-009305
Filing Date
2018-04-26
Accepted
2018-04-26 16:05:59
Documents
3
Period of Report
2018-06-14
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A atra-def14a_20180614.htm DEF 14A 625208
2 GRAPHIC g2018042614292722222064.jpg GRAPHIC 52492
3 GRAPHIC g2018042614292724622065.jpg GRAPHIC 47822
  Complete submission text file 0001564590-18-009305.txt   764716
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36548 | Film No.: 18778528
SIC: 2836 Biological Products, (No Diagnostic Substances)